Sunshine Biopharma (SBFM) EPS (Weighted Average and Diluted) (2021 - 2025)
Sunshine Biopharma (SBFM) reported EPS (Weighted Average and Diluted) of -$0.44 for Q1 2025, up 78.0% on a YoY basis from -$0.25 in Q1 2024, and up 85.69% quarter-over-quarter from -$3.08 in Q4 2024.
Sunshine Biopharma (SBFM) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
Sunshine Biopharma has reported EPS (Weighted Average and Diluted) for 5 years, with the latest figure at -$0.44 in Q1 2025.
- For the quarter ending Q1 2025, EPS (Weighted Average and Diluted) rose 78.0% year-over-year to -$0.44; the trailing twelve-month figure through Mar 2025 stood at -$2.34 (up 63.35% YoY), and the FY2024 full-year result was -$7.32, up 97.92% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2025 stood at -$0.44, up from -$3.08 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.26 in Q4 2021, with the low at -$97.47 in Q4 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged -$9.37 across 5 years, with a median of -$0.34 in 2025.
- Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) plunged 6193.06% — and 2024, when it surged 96.84%.
- Sunshine Biopharma's EPS (Weighted Average and Diluted) stood at $0.26 in 2021, then sank by 706.43% to -$1.55 in 2022, then sank by 6193.06% to -$97.47 in 2023, then soared by 96.84% to -$3.08 in 2024, then soared by 85.69% to -$0.44 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.44 (Q1 2025), -$3.08 (Q4 2024), and -$2.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Sunshine Biopharma | 11.70 Mn | 4.79 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -0.44 |
| Dec 31, 2024 | -3.08 |
| Mar 31, 2024 | -2.00 |
| Dec 31, 2023 | -97.47 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.04 |
| Mar 31, 2023 | -7.73 |
| Dec 31, 2022 | -1.55 |
| Sep 30, 2022 | -0.08 |
| Jun 30, 2022 | -0.06 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | 0.26 |